“padlock-therapeutics” Archives

in
Entry Author Date Location
JLABS Takes Stock of Its Experiment in Life Sciences Innovation 10/13/17 San Diego
IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout 08/03/17 Boston
Bristol Flips Remnants of Adnexus, iPierian to Roche, Biogen For $470M 04/13/17 New York
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills 02/27/17 Boston
VC Activity in Boston Dipped in 2016; Here Are the Top 10 Deals & Exits 01/11/17 Boston
Sofinnova, Atlas Put $35M Into Delinia to Tackle Autoimmune Diseases 09/14/16 Boston
East Coast Biotech Roundup: Harvard’s Haul, Patent Fights, Padlock & More 03/24/16 Boston
Gilman Scores for Atlas Again as Bristol Buys Padlock for up to $600M 03/23/16 Boston
Ragan Reunites Ex-Genzymers at X4 Pharma to Battle Cancer 09/01/15 Boston
East Coast Biotech Roundup: Seres, Editas, PureTech, Pronutria & More 05/29/15 Boston
Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups 04/17/15 Boston
From Iceland to White House, Precision Medicine’s Promises & Hurdles 03/31/15 National
East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More 12/19/14 Boston
Padlock Therapeutics Obtains $23,000,000 Series A Financing Round 12/19/14 Boston
Déjà Vu For Gilman as New Immunology Startup, Padlock, Gets $23M 12/18/14 Boston
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors 10/14/14 Boston
Scripps Unveils New Drug Development Arm, Signs J&J as First Partner 04/15/14 San Francisco
Page 1 of 1